Emerging dermatologic issues in the oncology patient.
The spectrum of skin diseases that occurs in the oncology patient differs somewhat from that seen in other immunosuppressed populations. We review the cutaneous manifestations of invasive mold infections in the leukemia/lymphoma population. Aspergillus mold infections are now the leading infectious cause of death in this population. We also review the pustular eruption caused by a new class of chemotherapy for solid malignancies. An update on cutaneous graft-versus-host disease appears elsewhere in this journal. Cutaneous squamous cell carcinomas and basal cell carcinomas occur more frequently in the chronic lymphocytic leukemia and non-Hodgkin's lymphoma population; this is discussed, as is the more aggressive clinical course of these tumors.
Mays
Steven R
SR
Department of Dermatology, MD Anderson Cancer Center, Houston, TX 77030, USA. stevenmays@earthlink.net
Cohen
Philip R
PR
D000970:Antineoplastic Agents / Q000009:adverse effects; D003881:Dermatomycoses / Q000175:diagnosis / Q000209:etiology; D003937:Diagnosis, Differential; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000209:etiology; D019337:Hematologic Neoplasms / Q000150:complications / Q000473:pathology; D006801:Humans; D016867:Immunocompromised Host; D009369:Neoplasms / Q000150:complications* / Q000473:pathology; D012871:Skin Diseases / Q000175:diagnosis / Q000209:etiology*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000556:secondary*
D000970:Antineoplastic Agents